Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 18 Jul 2020 |
2 | Reply to Exam Report (MIS-R) | 08 Sep 2020 |
3 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 03 Jan 2022 |
4 | Documents in support of Show cause Hearing (SCH) | 07 Sep 2022 |
5 | Journal Copy | 08 Nov 2023 |
6 | Certificate | 17 Nov 2023 |
1 | EXAMINATION REPORT | 10272725 | 13 Aug 2020 | |
2 | Hearing Notice (Show Cause) | 12402632 | 01 Nov 2021 | |
3 | Hearing Notice (Show Cause) | 13877297 | 02 Aug 2022 | |
4 | Hearing Notice (Show Cause) | 15251039 | 16 May 2023 | |
5 | Tribunal Accepted Notice for : 4574671 | 15450000 | 6012204 | 19 Jun 2023 |
Trademark was applied on 18 July 2020 with IP India.
Proprietor of Sovereign pharma is SOVEREIGN PHARMA.
Class(es) in which the trademark was applied to is 35.
Status of Sovereign pharma is Registered.
Application number alloted to the trademark is 4574671.
Lexorbis is the Trademark agent/attorney.
Trademark has been filed in the following category:
WORD